ATE128988T1 - Verfahren zur herstellung von komplexen aus mehrfachungesättigten fettsäuren mit langer kette und cyclodextrinen und die so erhaltenen komplexe. - Google Patents

Verfahren zur herstellung von komplexen aus mehrfachungesättigten fettsäuren mit langer kette und cyclodextrinen und die so erhaltenen komplexe.

Info

Publication number
ATE128988T1
ATE128988T1 AT91112558T AT91112558T ATE128988T1 AT E128988 T1 ATE128988 T1 AT E128988T1 AT 91112558 T AT91112558 T AT 91112558T AT 91112558 T AT91112558 T AT 91112558T AT E128988 T1 ATE128988 T1 AT E128988T1
Authority
AT
Austria
Prior art keywords
complexes
long chain
cyclodextrins
fatty acids
unsaturated fatty
Prior art date
Application number
AT91112558T
Other languages
English (en)
Inventor
Tiberio Bruzzese
Giovanni Mozzi
Original Assignee
Staroil Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Staroil Ltd filed Critical Staroil Ltd
Application granted granted Critical
Publication of ATE128988T1 publication Critical patent/ATE128988T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11CFATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
    • C11C1/00Preparation of fatty acids from fats, fatty oils, or waxes; Refining the fatty acids
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nanotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medical Informatics (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Fats And Perfumes (AREA)
AT91112558T 1990-08-09 1991-07-26 Verfahren zur herstellung von komplexen aus mehrfachungesättigten fettsäuren mit langer kette und cyclodextrinen und die so erhaltenen komplexe. ATE128988T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT02125790A IT1243192B (it) 1990-08-09 1990-08-09 Complessi di acidi grassi polinsaturi a lunga catena e di loro derivati, con ciclodestrine

Publications (1)

Publication Number Publication Date
ATE128988T1 true ATE128988T1 (de) 1995-10-15

Family

ID=11179136

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91112558T ATE128988T1 (de) 1990-08-09 1991-07-26 Verfahren zur herstellung von komplexen aus mehrfachungesättigten fettsäuren mit langer kette und cyclodextrinen und die so erhaltenen komplexe.

Country Status (11)

Country Link
US (1) US5189149A (de)
EP (1) EP0470452B1 (de)
JP (1) JPH072662A (de)
KR (1) KR920004555A (de)
AT (1) ATE128988T1 (de)
CA (1) CA2047884A1 (de)
DE (1) DE69113713T2 (de)
ES (1) ES2079526T3 (de)
IT (1) IT1243192B (de)
NO (1) NO305034B1 (de)
PT (1) PT98606B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19612658A1 (de) * 1996-03-29 1997-10-02 Wacker Chemie Gmbh Verfahren zur Stabilisierung und Dispergierung von Pflanzenölen, die mehrfach ungesättigte Fettsäurereste enthalten, mittels gamma-Cyclodextrin sowie derart hergestellte Komplexe und ihre Verwendung
FR2790758A1 (fr) * 1999-03-09 2000-09-15 Commissariat Energie Atomique Solubilisation d'acides gras polyinsatures et de leurs derives par formation de complexes d'inclusion avec une cyclodextrine et leur utilisation dans des compositions pharmaceutiques, cosmetiques ou alimentaires
EP1041136B1 (de) * 1999-04-01 2001-06-13 Wacker Biochem Corporation Verfahren zur Stabilisierung von Acylglycerinen, die einen hohen Anteil an w-3 mehrfach ungesättigten Fettsäuren enthalten, mittels gamma-Cyclodextrin
FR2825714B1 (fr) * 2001-06-08 2005-03-25 Seppic Sa Nouvelle utilisation de complexes d'inclusion de cyclodestrine
US6638557B2 (en) * 2001-08-14 2003-10-28 Cerestar Holding B.V. Dry, edible oil and starch composition
US20030190402A1 (en) * 2002-04-04 2003-10-09 Mcbride Christine Reduced fat foodstuff with improved flavor
PL220776B1 (pl) 2002-08-19 2016-01-29 Soho Flordis Internat Pty Ltd Zastosowanie α-cyklodekstryny do wytwarzania leku do zmniejszania biegunki
DE10253042A1 (de) * 2002-11-14 2004-06-03 Wacker-Chemie Gmbh Kosmetische Zubereitung enthaltend einen Komplex aus Cyclodextrin und Vitamin F
US20040109920A1 (en) * 2002-12-04 2004-06-10 Bioactives Llc Coated carotenoid cyclodextrin complexes
FR2850040B1 (fr) * 2003-01-20 2005-03-11 Centre Nat Rech Scient Systemes pour microencapsulation et leurs applications
US7125833B2 (en) * 2003-03-24 2006-10-24 Wacker Chemie Ag Cyclodextrin laundry detergent additive complexes and compositions containing same
WO2006004574A2 (en) * 2004-02-19 2006-01-12 Abbott Laboratories Method for using gamma cyclodextrin to control blood glucose and insulin secretion
US7781572B2 (en) * 2005-10-05 2010-08-24 Nse Products, Inc. Nanosized carotenoid cyclodextrin complexes
FR2898817B1 (fr) * 2006-03-23 2008-08-08 Univ Rouen Association de substance oleagineuse avec un melange d'au moins deux cyclodextrines
KR100832796B1 (ko) * 2006-08-23 2008-05-27 주식회사 마크로케어 사이클로덱스트린을 이용한 스쿠알렌 또는 스쿠알란의 추출방법 및 그 방법에 의해 제조된 포접체를 함유하는 화장료 조성물
ITMI20061672A1 (it) * 2006-09-01 2008-03-02 Altergon Sa Formulazioni di acido acetilsalicilico o suoi derivati in capsule molli,esibenti elevata stabilita'
EP2049083A2 (de) * 2006-12-27 2009-04-22 Cargill, Incorporated Cyclodextrin-einschlusskomplexe und verfahren zu ihrer herstellung
GB0710439D0 (en) * 2007-05-31 2007-07-11 Uni I Oslo Oral dosage form
ITMI20072142A1 (it) * 2007-11-08 2009-05-09 Yervant Zarmanian Composizioni farmaceutiche contenenti statine e derivati di acidi grassi omega-3
WO2009078030A1 (en) * 2007-12-17 2009-06-25 Alkem Laboratories Limited Fat substitute
GB0808479D0 (en) * 2008-05-09 2008-06-18 Uni I Oslo Topical compositions
GB0817701D0 (en) * 2008-09-26 2008-11-05 Omegatri As Krill oil powder and krill oil tablets
JP5572323B2 (ja) * 2009-03-04 2014-08-13 備前化成株式会社 包摂反応においてホスト化合物の選択性を高める低分子多糖類、およびそれを用いた苦味成分および臭い成分を包摂する方法
DE102010023790A1 (de) 2010-06-15 2011-12-15 Heinrich-Heine-Universität Düsseldorf Waschaktive Zusammensetzung
ITMI20112244A1 (it) * 2011-12-12 2013-06-13 S I I T S R L Complesso di inclusione tra una ciclodestrina e un olio vegetale e suo impiego
CN107666904B (zh) 2015-03-26 2022-02-01 提贝托·布鲁泽塞 多不饱和脂肪酸的纯化组合物、其制备方法及其用途
CN117860766A (zh) * 2016-04-27 2024-04-12 物心科技株式会社 含有醚型甘油磷脂的组合物和其制造方法
US20230302152A1 (en) * 2019-10-16 2023-09-28 Sefacor Inc. Cyclodextrin-based gammalinolenic acid formulation for treatment of brain cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2827452A (en) * 1955-05-31 1958-03-18 Univ Minnesota Stabilization of materials
JPS5813541A (ja) * 1981-07-16 1983-01-26 Kureha Chem Ind Co Ltd エイコサペンタエン酸又はドコサヘキサエン酸のシクロデキストリン包接化合物
JPS6034156A (ja) * 1983-08-08 1985-02-21 Hayashibara Biochem Lab Inc エイコサペンタエン酸包接化合物及びこれを含有した飲食物
FR2596617B1 (fr) * 1986-04-08 1990-10-05 Orstom Composition a base d'acide gras complexe par des cyclodextrines, son procede de preparation et application phytosanitaire
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition

Also Published As

Publication number Publication date
CA2047884A1 (en) 1992-02-10
IT9021257A1 (it) 1992-02-09
DE69113713D1 (de) 1995-11-16
EP0470452B1 (de) 1995-10-11
ES2079526T3 (es) 1996-01-16
EP0470452A2 (de) 1992-02-12
PT98606B (pt) 1999-01-29
IT1243192B (it) 1994-05-24
NO913083D0 (no) 1991-08-08
NO913083L (no) 1992-02-10
JPH072662A (ja) 1995-01-06
PT98606A (pt) 1992-06-30
KR920004555A (ko) 1992-03-27
US5189149A (en) 1993-02-23
NO305034B1 (no) 1999-03-22
DE69113713T2 (de) 1996-03-21
EP0470452A3 (en) 1992-04-29
IT9021257A0 (it) 1990-08-09

Similar Documents

Publication Publication Date Title
ATE128988T1 (de) Verfahren zur herstellung von komplexen aus mehrfachungesättigten fettsäuren mit langer kette und cyclodextrinen und die so erhaltenen komplexe.
DE69103062D1 (de) Verfahren zur Herstellung von ungesättigten Aldehyden und ungesättigten Säuren.
ATE82576T1 (de) Verfahren zur herstellung von nphosphonmethylglyzin.
ATE248815T1 (de) Verfahren zur herstellung einer wässrigen monoester percarbonsäurelösung
AT358017B (de) Verfahren zur herstellung neuer phenoxyalkan- saeuren, deren ester und salze
DE68913714D1 (de) Verfahren zur Herstellung von ungesättigter Carbonsäure oder ihrem Ester.
DE69214686D1 (de) Verfahren zur Herstellung von Polyestern mit verbesserter thermooxydativer Stabilität
ATE795T1 (de) Verfahren zur herstellung von metallseifen.
ATE136549T1 (de) Verfahren zur herstellung von aus di- oder tri- carboxylsäuren abgeleiteten grenzflächenaktiven mitteln
ATE178898T1 (de) Verfahren zur herstellung von alkyl ketendimeren
ATE201025T1 (de) Verfahren zur herstellung von cephalosporinen und zwischenprodukte in diesem verfahren
CH557389A (de) Verfahren zur herstellung von neuen diphenylmethan-, diphenyloxid- und diphenylsulfid-phosphonig und-thiophosphonigsaeuren, deren ester und thioester.
ATE116237T1 (de) Behälter und verfahren zu seiner herstellung.
DE59100877D1 (de) Verfahren zur Herstellung von Carbonsäurechloriden.
ATE129015T1 (de) Verfahren zur herstellung von mehrfach ungesättigten fettsäuren mit ungerader zahl von kohlenstoffatomen.
ATE127470T1 (de) Verfahren zur herstellung von phosphatidylcholinderivaten.
DE69220875D1 (de) Verbessertes Verfahren zur Herstellung von 4-Halogenchinazoline
AT384222B (de) Verfahren zur herstellung von 7-amino-3alkoxymethyl-3-cephem-4-carbonsaeuren
ATE121410T1 (de) Verfahren zur herstellung von diphosphonsäuren und salzen davon.
DE58905010D1 (de) Verfahren zur herstellung von 5-chlor-3-chlorsulfonyl-2-thiophencarbonsaeureestern.
DE58901307D1 (de) Verfahren zur herstellung von 4-halo-3-oxo-2-alkoxyiminobuttersaeureestern.
DE68911168D1 (de) Verfahren zur Herstellung von ungesättigten Carbonsäuren.
DE69400978D1 (de) Verfahren zur Herstellung von L-(-)-Carnitin aus Abfallprodukten mit entgegengesetzter Konfiguration
DE59104041D1 (de) Verfahren zur Herstellung von Carbonsäurechloriden.
ATE151072T1 (de) Verfahren zur herstellung von substituierten und nicht substituierten 2,3-pyridin und chinolincarbonsäuren

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee